BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10192171)

  • 1. The in vitro effect of hydroxychloroquine on skin morphology in psoriasis.
    Wolf R; Schiavo AL; Lombardi ML; de Angelis F; Ruocco V
    Int J Dermatol; 1999 Feb; 38(2):154-7. PubMed ID: 10192171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro effect of hydroxychloroquine on skin morphology and transglutaminase.
    Wolf R; Lo Schiavo A; Lombardi ML; Esposito C; Ruocco V
    Int J Dermatol; 1997 Sep; 36(9):704-7. PubMed ID: 9352417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggered psoriasis.
    Wolf R; Ruocco V
    Adv Exp Med Biol; 1999; 455():221-5. PubMed ID: 10599347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gemfibrozil on in vitro cultured normal human skin explants.
    Wolf R; Lo Schiavo A; Russo A; de Angelis F; Ruocco V
    Int J Dermatol; 1999 Jan; 38(1):65-9. PubMed ID: 10065615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lithium carbonate (Li2CO3) on in-vitro-cultured normal human skin explants.
    Wolf R; D'Avino M; De Angelis F; Ruocco E; Lombardi ML
    J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):97-9. PubMed ID: 10972093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin.
    Gerritsen MJ; Elbers ME; de Jong EM; van de Kerkhof PC
    J Dermatol Sci; 1997 Mar; 14(3):179-88. PubMed ID: 9138475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
    Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN
    Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin Inflammation.
    Ogawa T; Ishitsuka Y; Inoue S; Nakamura Y; Saito A; Okiyama N; Fujisawa Y; Furuta J; Watanabe R; Fujimoto M
    Am J Pathol; 2020 Mar; 190(3):577-585. PubMed ID: 31953037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
    Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
    Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin.
    Harrison CA; Layton CM; Hau Z; Bullock AJ; Johnson TS; MacNeil S
    Br J Dermatol; 2007 Feb; 156(2):247-57. PubMed ID: 17223863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
    Abe J; Kondo S; Nishii Y; Kuroki T
    J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cultured keratinocytes and fibroblasts from human psoriatic and normal skin in immunodeficient mice.
    Sugai J; Katakai Y; Iizuka M; Kawakubo Y; Ozawa A; Ohkido M; Ueyama Y; Tamaoki N; Inokochi S; Shimamura K
    J Dermatol Sci; 1998 Jul; 17(3):190-7. PubMed ID: 9697047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast-keratinocyte interactions in psoriasis: failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro.
    Priestley GC; Lord R
    Br J Dermatol; 1990 Oct; 123(4):467-72. PubMed ID: 2095178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
    Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
    J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
    Grossman RM; Krueger J; Yourish D; Granelli-Piperno A; Murphy DP; May LT; Kupper TS; Sehgal PB; Gottlieb AB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6367-71. PubMed ID: 2474833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.
    de Mare S; Van Erp PE; van de Kerkhof PC
    J Invest Dermatol; 1989 Jan; 92(1):130-1. PubMed ID: 2462594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment.
    Gerritsen MJ; Rulo HF; Arnold WP; Van de Kerkhof PC
    Br J Dermatol; 1994 Feb; 130(2):181-8. PubMed ID: 7510122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model.
    Jean J; Soucy J; Pouliot R
    Tissue Eng Part A; 2011 Jul; 17(13-14):1859-68. PubMed ID: 21417679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.